Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Not Confirmed
Not Confirmed
22-23 September, 2025
Not Confirmed
Not Confirmed
25-26 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
World Drug Safety EUWorld Drug Safety EU
Industry Trade Show
Not Confirmed
22-23 September, 2025
Industry Trade Show
Not Confirmed
25-26 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
16 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-16/newron-presents-h1-2025-results-and-provides-business-update
05 Sep 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-09-05/newron-to-present-data-and-updates-on-its-clinical-program-evaluating-evenamide-as-an-add-on-treatme
12 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250812127452/en/Newron-Begins-Enrollment-in-Pivotal-Phase-III-ENIGMA-TRS-Program-With-Evenamide-as-Add-on-Therapy-in-Patients-With-Treatment-Resistant-Schizophrenia-TRS
11 Aug 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250811493586/en/Newron-Notes-the-Publication-of-New-Preclinical-Research-Suggesting-Evenamide-Ameliorates-Schizophrenia-Related-Dysfunction
11 Aug 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-08-11/newron-notes-the-publication-of-new-preclinical-research-suggesting-evenamide-ameliorates-schizophre
12 May 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250512167812/en/Newron-Announces-Approval-for-Pivotal-Phase-III-ENIGMA-TRS-Program-With-Evenamide-as-Add-on-Therapy-in-Patients-With-Treatment-resistant-Schizophrenia-TRS
ABOUT THIS PAGE